What’s New

  • Wounds logo
    Visit the SAWC Newsroom for the Latest Coverage
    SAWC Spring | WHS is the largest and most influential wound care conference providing clinicians with comprehensive education. Visit the newsroom throughout the conference for ongoing coverage.
  • Podiatry Today Podcast logo
    Listen to the Podiatry Today Podcast Today!
    Podiatry Today Podcasts delivers practical, expert-driven insights for today’s foot and ankle specialist, with a strong focus on topics including surgical techniques, sports medicine, limb salvage, and dermatologic conditions of the lowe...
  • Neurology Learning Network logo
    The Neurologist Is In Podcasts
    Check out the latest episodes of The Neurologist is In podcast series with host Rachel Marie E. Salas, MD, MEd.

Latest News

spilled bottle of white pills
News
Tazbentetol Demonstrates Early Symptom Improvement in Phase 2 Schizophrenia Trial
04/01/2026
Maria Mantas
Interim results from a phase 2 randomized, double-blind, placebo-controlled trial of tazbentetol demonstrated early signals of efficacy across schizophrenia symptom domains.
Interim results from a phase 2 randomized, double-blind, placebo-controlled trial of tazbentetol demonstrated early signals of efficacy across schizophrenia symptom domains.
Interim results from a phase 2...
04/01/2026
Psych Congress Network
Psych Congress Network
News
Dose-Reduced Chemotherapy Expands Treatment Options for Frail Patients with Metastatic Colorectal Cancer
04/01/2026
Emily Estrada
Results from the phase 2 ELDERLY trial demonstrated that dose-reduced chemotherapy regimens show clinical activity with a manageable safety profile in elderly and frail elderly patients with metastatic colorectal cancer.
Results from the phase 2 ELDERLY trial demonstrated that dose-reduced chemotherapy regimens show clinical activity with a manageable safety profile in elderly and frail elderly patients with metastatic colorectal cancer.
Results from the phase 2 ELDERLY...
04/01/2026
Oncology
Oncology
News
Dupilumab Significantly Increases Itch- and Hive-Free Days in Chronic Spontaneous Urticaria
04/01/2026
Riya Gandhi, MA
Phase 3 data show more than 19 additional symptom-free days with dupilumab vs placebo over 24 weeks.
Phase 3 data show more than 19 additional symptom-free days with dupilumab vs placebo over 24 weeks.
Phase 3 data show more than 19...
04/01/2026
The Dermatologist
The Dermatologist
Acute Pulmonary Embolism
HI-PEITHO Trial Demonstrates Boston Scientific EKOS™ Endovascular System Is Superior to Standard of Care for Treatment of Acute Pulmonary Embolism
04/01/2026
Global randomized trial demonstrated statistically significant reduction in clinical event rates in patients with intermediate-risk PE when treated with the EKOS device plus anticoagulation vs. anticoagulation alone Late breaking findings...
Global randomized trial demonstrated statistically significant reduction in clinical event rates in patients with intermediate-risk PE when treated with the EKOS device plus anticoagulation vs. anticoagulation alone Late breaking findings...
Global randomized trial...
04/01/2026
Vascular Disease Management
Vascular Disease Management
News
Glofitamab Plus Polatuzumab Shows Strong Responses in R/R LBCL
03/31/2026
Grace Taylor, MS, MA
Glofitamab plus polatuzumab vedotin delivered high response rates and durable outcomes in heavily pretreated relapsed or refractory large B-cell lymphoma (R/R LBCL), including high-risk subgroups and prior chimeric antigen receptor (CAR)...
Glofitamab plus polatuzumab vedotin delivered high response rates and durable outcomes in heavily pretreated relapsed or refractory large B-cell lymphoma (R/R LBCL), including high-risk subgroups and prior chimeric antigen receptor (CAR)...
Glofitamab plus polatuzumab...
03/31/2026
First Report Managed Care
First Report Managed Care
News
New Study Finds BIOTRONIK’s CRT-DX Technology Enables Effective CRT-D Therapy with Fewer Leads
03/31/2026
Results from the multicenter CRT‑NEXT Study show that CRT‑DX, BIOTRONIK’s 2-lead CRT-D system, is as safe and effective as conventional 3-lead CRT‑D therapy. The study confirms that most CRT candidates do not develop the need for atrial...
Results from the multicenter CRT‑NEXT Study show that CRT‑DX, BIOTRONIK’s 2-lead CRT-D system, is as safe and effective as conventional 3-lead CRT‑D therapy. The study confirms that most CRT candidates do not develop the need for atrial...
Results from the multicenter...
03/31/2026
EP Lab Digest
EP Lab Digest

Latest Research

Podiatry Today logo
Podiatry Today
Comprehensive Compression Therapy for the Lower Extremities
Vol. 39, Issue 4, Issue April 2026
Journal of Critical Limb Ischemia logo
Journal of Critical Limb Ischemia
System Matters: How Structure and Access Shape CLTI Outcomes
Vol. 6, Issue 1, Issue April 2026

HMP Global Learning Network

Featured Interviews

Advanced Squamous Cell Carcinoma of the Anal Canal
Videos
Evaluating Retifanlimab for Advanced Squamous Cell Carcinoma of the Anal Canal in the Frontline Setting
03/31/2026
Lingbin Meng, MD, PhD
Lingbin Meng, MD, discusses how adding retifanlimab to chemotherapy may reshape frontline treatment for advanced squamous cell carcinoma of the anal canal.
Lingbin Meng, MD, discusses how adding retifanlimab to chemotherapy may reshape frontline treatment for advanced squamous cell carcinoma of the anal canal.
Lingbin Meng, MD, discusses how...
03/31/2026
First Report Managed Care
Rachid Baz, MD
Videos
BCMA-Targeted Bispecifics and CAR-T in Frontline Multiple Myeloma
03/31/2026
Rachid Baz, MD
Rachid Baz, MD, discusses the emerging role of BCMA-targeted bispecific antibodies and CAR T-cell therapy in transplant-ineligible patients with newly diagnosed multiple myeloma.
Rachid Baz, MD, discusses the emerging role of BCMA-targeted bispecific antibodies and CAR T-cell therapy in transplant-ineligible patients with newly diagnosed multiple myeloma.
Rachid Baz, MD, discusses the...
03/31/2026
Oncology
Gustavo Oderich, MD, Robert Rhee, MD, and Sukgu Han, MD
sponsored video
Gustavo Oderich, MD, Robert Rhee, MD, and Sukgu Han, MD Discuss Evolving Treatment Algorithms in AAA Repair of Short, Angulated Necks
03/31/2026
Gustavo S. Oderich, MD; Robert Rhee, MD; Sukgu Han, MD
Three experts share their perspective on the GORE EXCLUDER Conformable AAA Endoprosthesis.
Three experts share their perspective on the GORE EXCLUDER Conformable AAA Endoprosthesis.
Three experts share their...
03/31/2026
Vascular Disease Management
Julie Carbray, PhD, APRN, PMHNP-BC
Videos
Optimizing ADHD Outcomes With Stimulant and Non-Stimulant Options
03/31/2026
Julie Carbray PhD, PMHNP-BC, PMHCNS-BC, APRN
Psych Congress NP Institute Co-Chair Julie Carbray, PhD, PMHNP-BC, PMHCNS-BC, FAAN, explains key differences in stimulant and non-stimulant treatment options for ADHD.
Psych Congress NP Institute Co-Chair Julie Carbray, PhD, PMHNP-BC, PMHCNS-BC, FAAN, explains key differences in stimulant and non-stimulant treatment options for ADHD.
Psych Congress NP Institute...
03/31/2026
Psych Congress NP Institute
Al B. Benson, III, MD, FACP, FASCO
Videos
First-Line Immunotherapy in Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC): Evidence Review
03/31/2026
Al B. Benson, III, MD, FACP, FASCO
Dr Benson reviews the epidemiology and unmet clinical need in advanced squamous cell carcinoma of the anal canal (SCAC) and examines the evolving role of immunotherapy in the first-line setting. He also contextualizes recent regulatory and...
Dr Benson reviews the epidemiology and unmet clinical need in advanced squamous cell carcinoma of the anal canal (SCAC) and examines the evolving role of immunotherapy in the first-line setting. He also contextualizes recent regulatory and...
Dr Benson reviews the...
03/31/2026
First Report Managed Care
Ira Zackon, MD
Videos
Real-World Analysis Finds Venetoclax-Based Induction Effective for Very Elderly Patients With Acute Myeloid Leukemia
03/02/2026
Ira Zackon, MD
Ira Zackon, MD, shared results from a large real-world analysis which found venetoclax plus a hypomethylating agent is a feasible and effective therapeutic option for patients with AML aged 70 years and older.
Ira Zackon, MD, shared results from a large real-world analysis which found venetoclax plus a hypomethylating agent is a feasible and effective therapeutic option for patients with AML aged 70 years and older.
Ira Zackon, MD, shared results...
03/02/2026
Oncology
Pediatric Video Tutorial: Communicating With Deaf Patients Part 2
Videos
Pediatric Video Tutorial: Communicating With Deaf Patients Part 2
03/02/2026
Scott DeBoer, RN, MSN, CPEN, CEN, CCRN, CFRN
With invaluable insights from a certified interpreter for the deaf, part two of this four-part series rapidly reviews what medical professionals really need to know, and what their deaf patients wish their caregivers knew.
With invaluable insights from a certified interpreter for the deaf, part two of this four-part series rapidly reviews what medical professionals really need to know, and what their deaf patients wish their caregivers knew.
With invaluable insights from a...
03/02/2026
EMSWorld
Allen Kaplan
RESEARCH INSIGHTS
Diagnostic Challenges and Clinical Pitfalls in HAE
03/02/2026
Allen P. Kaplan, MD
Dr Allen Kaplan reviews common diagnostic pitfalls in hereditary angioedema, including misinterpretation of complement testing, confusion with histaminergic angioedema, and challenges in identifying HAE with normal C1 inhibitor.
Dr Allen Kaplan reviews common diagnostic pitfalls in hereditary angioedema, including misinterpretation of complement testing, confusion with histaminergic angioedema, and challenges in identifying HAE with normal C1 inhibitor.
Dr Allen Kaplan reviews common...
03/02/2026
Allergy & Immunology
Zeymer title card
Author Interview
Hospital Outcomes of Patients With Acute Myocardial Infarction-Related Cardiogenic Shock With and Without Revascularization: An Interview With Uwe Zeymer, MD
02/27/2026
Uwe Zeymer, MD
Dr Uwe Zeymer shares background and insights on his article, "Hospital Outcomes of Patients With Acute Myocardial Infarction-Related Cardiogenic Shock With and Without Revascularization."
Dr Uwe Zeymer shares background and insights on his article, "Hospital Outcomes of Patients With Acute Myocardial Infarction-Related Cardiogenic Shock With and Without Revascularization."
Dr Uwe Zeymer shares background...
02/27/2026
Journal of Invasive Cardiology
tourniquet stop the bleed DeBoer
Videos
Pediatric Video Tutorial: Stop the Bleed Part 2—Tourniquet Tips
01/30/2026
Scott DeBoer, RN, MSN, CPEN, CEN, CCRN, CFRN
When it comes to tourniquets, whether for little ones or big people, practice and proper placement can be lifesavers.
When it comes to tourniquets, whether for little ones or big people, practice and proper placement can be lifesavers.
When it comes to tourniquets,...
01/30/2026
EMSWorld

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use